marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 12-16-2024
Enzo Biochem Balance Sheet 2011-2024 | ENZ
Annual Balance Sheet Enzo Biochem
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-51.3 M | -81.1 M | -16.6 M | -5.75 M | -39.3 M | -55.5 M | -59.7 M | -63.6 M | -66.1 M | -14.7 M | -16.9 M | -8.56 M | -15.1 M | -14.2 M |
Long Term Debt |
189 K | 269 K | 4.08 M | 4.36 M | 4.48 M | 4.18 M | 2 K | 22 K | 105 K | 363 K | 369 K | 269 K | - | - |
Long Term Debt Current |
841 K | 980 K | 896 K | 3.42 M | 4.12 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 4.6 M | 353 K | 983 K | 1.7 M | 1.83 M | 2.5 M | 974 K | 1.07 M | 3.03 M |
Total Current Liabilities |
24.8 M | 40 M | 13 M | 26.1 M | 32.8 M | 16 M | 20.2 M | 17.8 M | 20.6 M | 24 M | 25 M | 23.9 M | 19 M | - |
Total Liabilities |
29.7 M | 43.4 M | 21.1 M | 45.1 M | 54.2 M | 20.6 M | 20.5 M | 18.8 M | 22.3 M | 25.8 M | 27.5 M | 24.8 M | 20 M | 20.8 M |
Deferred Revenue |
- | - | - | 2.68 M | 2.53 M | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-294 M | -268 M | -289 M | -270 M | -278 M | -250 M | -252 M | -242 M | -239 M | -285 M | -282 M | -272 M | -254 M | -215 M |
Total Assets |
85.8 M | 122 M | 75.6 M | 114 M | 113 M | 107 M | 102 M | 108 M | 112 M | 68.4 M | 64.4 M | 59 M | 69.1 M | 109 M |
Cash and Cash Equivalents |
52.4 M | 82.4 M | 21.6 M | 13.5 M | 47.9 M | 60.1 M | 60 M | 64.2 M | 67.8 M | 18.1 M | 17.5 M | 9.01 M | 15.1 M | 14.2 M |
Book Value |
56.1 M | 78.5 M | 54.5 M | 68.6 M | 58.4 M | 86 M | 81.1 M | 88.9 M | 89.6 M | 42.6 M | 37 M | 34.1 M | 49.1 M | 88.7 M |
Total Shareholders Equity |
56.1 M | 78.5 M | 54.5 M | 68.6 M | 58.4 M | 86 M | 81.1 M | 88.9 M | 89.6 M | 42.6 M | 37 M | 34.1 M | 49.1 M | 88.7 M |
All numbers in USD currency
Quarterly Balance Sheet Enzo Biochem
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
155 K | 189 K | 180 K | 234 K | 219 K | 269 K | 247 K | 4.27 M | 3.99 M | 4.08 M | 4.18 M | 4.43 M | 4.31 M | 4.36 M | 4.36 M | 4.14 M | 4.45 M | 4.48 M | 4.48 M | - | 4.18 M | 4.18 M | - | 67 K | - | 2 K | 44 K | - | 102 K | 22 K | - | - | - | 105 K | - | - | - | 363 K | - | - | - | 369 K | - | - | - | 269 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
27.6 M | 29.7 M | 24.4 M | 28.3 M | 32 M | 43.4 M | 53.1 M | 43.7 M | 40.2 M | 41.4 M | 41.7 M | 50.2 M | 41.4 M | 45.1 M | 45.1 M | 45.9 M | 54.5 M | 54.2 M | 54.2 M | 21.6 M | 46.9 M | 20.6 M | 20 M | 20.4 M | 18.5 M | 20.5 M | 20.5 M | 18.7 M | 20.1 M | 18.8 M | 18.8 M | 26.5 M | 22 M | 22.3 M | 22.3 M | 24.7 M | 27.2 M | 25.8 M | 25.8 M | 23.5 M | 26.5 M | 27.5 M | 27.5 M | - | 25.2 M | 24.8 M | 24.8 M | - | 20 M | 20 M | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-298 M | -294 M | -281 M | -278 M | -275 M | -268 M | -326 M | -275 M | -299 M | -289 M | -280 M | -276 M | -273 M | -270 M | -270 M | -265 M | -278 M | -278 M | -278 M | -267 M | -257 M | -250 M | -244 M | -243 M | -258 M | -252 M | -252 M | -242 M | -243 M | -242 M | -242 M | -273 M | -241 M | -239 M | -239 M | -290 M | -280 M | -285 M | -285 M | -279 M | -286 M | -282 M | -282 M | -264 M | -275 M | -272 M | -272 M | -224 M | -258 M | -254 M | -254 M | - | -219 M | -215 M | -215 M |
Total Assets |
75.3 M | 85.8 M | 93.5 M | 99.1 M | 106 M | 122 M | 72.1 M | 109 M | 85.2 M | 95.9 M | 104 M | 112 M | 108 M | 114 M | 114 M | 117 M | 114 M | 113 M | 113 M | - | 125 M | 107 M | 111 M | 2.06 M | 94.2 M | 102 M | 102 M | 1.85 M | 109 M | 108 M | 108 M | 2.18 M | 110 M | 112 M | 112 M | 2.15 M | 74.4 M | 68.4 M | 68.4 M | 2.13 M | 62.6 M | 64.4 M | 64.4 M | 2.53 M | 58.3 M | 59 M | 59 M | 2.96 M | 67 M | 69.1 M | 69.1 M | 3.25 M | 104 M | 109 M | 109 M |
Cash and Cash Equivalents |
47.7 M | 52.4 M | 57.2 M | 60.2 M | 69.2 M | 82.4 M | 2.63 M | 5.05 M | 12.1 M | 21.6 M | 31.1 M | 44.5 M | 6.36 M | 13.5 M | 13.5 M | 51.5 M | 45.9 M | 47.9 M | 45.9 M | 42 M | 56.9 M | 60.1 M | 64.1 M | 64.2 M | 52.8 M | 60 M | 52.8 M | 67.4 M | 66.8 M | 64.2 M | 66.8 M | 37 M | 67.2 M | 67.8 M | 67.2 M | 15.3 M | 30.6 M | 18.1 M | 30.6 M | 7.62 M | 16.6 M | 17.5 M | 16.6 M | 10 M | 7.43 M | 9.01 M | 7.43 M | 8.59 M | 13.4 M | 15.1 M | 13.4 M | 8.99 M | 11.4 M | 14.2 M | 11.4 M |
Book Value |
47.7 M | 56.1 M | 69 M | 70.8 M | 74.3 M | 78.5 M | 18.9 M | 65.1 M | 45 M | 54.5 M | 62.2 M | 61.8 M | 66.8 M | 68.6 M | 68.6 M | 70.9 M | 59 M | 58.4 M | 58.4 M | -21.6 M | 78.3 M | 86 M | 91 M | -18.3 M | 75.7 M | 81.1 M | 81.1 M | -16.8 M | 89.2 M | 88.9 M | 88.9 M | -24.3 M | 88.5 M | 89.6 M | 89.6 M | -22.5 M | 47.2 M | 42.6 M | 42.6 M | -21.4 M | 36.1 M | 37 M | 37 M | 2.53 M | 33.1 M | 34.1 M | 34.1 M | 2.96 M | 47 M | 49.1 M | 69.1 M | 3.25 M | 104 M | 109 M | 109 M |
Total Shareholders Equity |
47.7 M | 56.1 M | 69 M | 70.8 M | 74.3 M | 78.5 M | 18.9 M | 32.8 M | 45 M | 54.5 M | 62.2 M | 61.8 M | 66.8 M | 68.6 M | 66.8 M | 70.9 M | 59 M | 59 M | 59 M | 67.5 M | 78.3 M | 78.3 M | 91 M | 88 M | 75.7 M | 81.1 M | 75.7 M | 87.7 M | 89.2 M | 88.9 M | 89.2 M | 54.4 M | 88.5 M | 89.6 M | 89.6 M | 34.9 M | 47.2 M | 42.6 M | 42.6 M | 32.2 M | 36.1 M | 37 M | 37 M | 40.3 M | 33.1 M | 34.1 M | 34.1 M | 78.8 M | 45.7 M | 49.1 M | 49.1 M | - | 83.5 M | 88.7 M | 88.7 M |
All numbers in USD currency